Finanzen von Applied Therapeutics Inc (APLT)APLTApplied Therapeutics Inc

Evaluating the bottom line, Applied Therapeutics Inc maintains a gross margin of 100.00%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -1675.80%, while the net margin is -1899.00%. These profitability ratios, combined with a Return on Equity (ROE) of -680.47%, provide a clear picture of how effectively APLT converts its operational activities into shareholder value.

In the context of the broader market, APLT competes directly with industry leaders such as LIMN and KALA. With a market capitalization of N/A, it holds a significant position in the sector. When comparing efficiency, APLT's gross margin of 100.00% stands against LIMN's N/A and KALA's N/A. Such benchmarking helps identify whether Applied Therapeutics Inc is trading at a premium or discount relative to its financial performance.